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Objective: To evaluate the effectiveness of a night-time hand 
positioning splint in patients with rheumatoid arthritis.
Design: Randomized controlled trial.
Methods: Fifty patients with rheumatoid arthritis were di-
vided randomly into 2 groups. The study group used a night-
time splint starting at baseline, while the control group used 
the splint only during evaluations. All patients attended eval-
uations wearing their splints, so that the assessor remained 
blinded to patient allocation. The splints used in the control 
group were stored in a cabinet between assessments. Partici-
pants were evaluated at baseline, 45 and 90 days, using the 
visual analogue scale for pain; the Jamar dynamometer for 
grip strength; a pinch gauge for pinch strength; a Health 
Assessment Questionnaire for function; the Disability of the 
Arm, Shoulder and Hand (DASH) questionnaire for upper 
limb disability and symptoms; and a Likert scale for patient 
satisfaction with treatment. 
Results: The groups were homogenous for all parameters 
at baseline. Pain, Health Assessment Questionnaire score, 
DASH score, grip strength and pinch strength were signifi-
cantly different between groups over time and satisfaction 
with the splint was reported as “better” and “much better” 
by most participants.
Conclusion: The use of a night-time hand positioning splint 
reduces pain, improves grip and pinch strength, upper limb 
function and functional status in patients with rheumatoid 
arthritis.
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INTRODUCTION
Rheumatoid arthritis (RA) is a chronic, multisystemic disease 
of unknown aetiology, whose main characteristic is persistent 
inflammatory synovitis that affects the peripheral joints in a sym-
metric and additive manner (1, 2). The main signs and symptoms 
observed during the active phase of the disease are joint pain, 
oedema and morning stiffness (3, 4). Involvement of the wrist 
and fingers is observed in approximately 75% of cases, and these 
individuals usually feel the effects of the disease in the hands and 
upper limbs, with a marked impact on functional skills (5–7). 
Splints are external devices applied to a body segment, 
whose aim is to offer support to joints, providing the best align-
ment possible (8, 9). Night-time splints maintain the hand in 
a resting position, promoting joint protection in patients with 
RA. These splints are frequently manufactured by occupational 
therapists and some authors recommend the use of a night-time 
splint to promote local rest, suggesting that this rest reduces 
inflammation and pain (10, 11). However, studies regarding 
the use of these splints, specifically in RA, are scarce (12, 
13). A recent systematic review concluded that there are few 
quality publications regarding the use of splints in RA and that 
the evidence is insufficient to draw conclusions regarding the 
effectiveness of these devices in reducing pain or increasing 
functional capacity in patients with RA (14).
We found no studies in the literature confirming the effec-
tiveness of these splints in patients with RA. In the present 
study, we evaluate the effectiveness of a night-time positioning 
hand splint in patients with RA in terms of pain, grip and pinch 
strength, upper limb function and patient satisfaction.
MeTHodS
Subjects
Fifty patients diagnosed with RA were recruited sequentially from 
the outpatient clinics of the Rheumatology division at the Federal 
University of São Paulo, SP, Brazil. Patients of both genders, rang-
ing in age from 18 to 65 years, with RA classified according to the 
American College of Rheumatology (ACR) criteria (15) presenting 
the following characteristics were included in the study: use of the 
same remissive drugs (disease modification antirheumatic drugs) for 
at least 6 months prior to intervention and the same doses of corti-
costeroids and non-steroidal anti-inflammatory drugs for at least one 
month prior to the study; a score ≥ 3 and ≤ 7 on a visual analogue scale 
(VAS) for pain in the more affected hand. We excluded patients who 
presented deformities in the more affected hand that did not permit 
the fabrication of the splint; those using any other type of upper limb 
splint; those with surgery scheduled within 6 months following the 
study; those allergic to the splint material; and those who lived in 
inaccessible areas with difficult access to transportation. The study 
was approved by the ethics committee of the Federal University of 
São Paulo. Patients who fulfilled the criteria were randomized into 
2 groups of 25 subjects each. Randomization was performed using 
opaque envelopes with concealed allocation.
Sample size
A minimum of 22 patients per group was necessary in order to achieve 
improvements in VAS pain of 3.0, with an alpha of 0.05 and a beta of 
0.20. However, 25 patients were randomized as a previous compensa-
tion for a possible 20% loss during follow-up.
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Outcome measures
The patients underwent 3 assessments: at baseline (T0), 45 days (T45) 
and 90 days (T90). All evaluations were performed by the same physi-
otherapist, who was trained in the tests used in the study and who was 
blind to patient allocation. In all assessments, patients were first seen 
by the occupational therapist responsible for the study, which examined 
splints on the patients in the study group (SG) and placed splints on 
the patients in the control group (CG). All patients were sent to the 
assessor with their splints to perform the evaluations. The splints used 
in the CG were stored in a cabinet between assessments. Patients were 
instructed not to comment on splint use to the assessor.
The primary outcome was:
•	 Pain: hand pain, as rated on a VAS ranging from 0 to 10 cm (16).
Secondary outcome measures included:
•	 Functional status: Health Assessment Questionnaire (HAQ), the final 
scores range from 0 to 3 and higher scores indicate more difficulty 
in performing activities of daily living. The HAQ was administered 
in interview form (17); 
•	 Upper limb disability and symptoms: Disabilities of the Arm, Shoul-
der and Hand (dASH) Questionnaire, the final scores range from 0 
to 100 and higher scores indicate more disabilities. Three modules 
of dASH scores were used: the optional modules for sports (Q1–4 
questions), music or work (Q2–4 questions) and disability/symptom 
score (Q3–30 questions). The dASH modules were administered in 
interview form (18–20);
•	 Pinch strength: both hands was evaluated with the patient seated 
and relaxed, with the elbow at 90º of flexion and a neutral posi-
tion of the wrist (between prone and supine) using a Pinch gauge 
(A853-4, Smith & Nephew, Germantown, Tennessee, USA) (21). 
The 3 common types of pinch (tip, key and palmar) were evaluated 
and the mean of 3 measurements in kilogram force (kgf) was used 
for analysis. The assessor gave verbal instructions to the patient in 
order to stimulate and improve strength at every measurement.
•	 Grip strength: both hands was evaluated with patient seated and 
relaxed, with the elbow at 90º of flexion and a neutral position of 
the wrist (between prone and supine) using a Jamar dynamometer 
(PC 5030J1, Preston, Trenton, ontario, Canada) (21). The Jamar 
handle was placed in the Number 2 position, according to the manu-
facturer's instructions. The mean of 3 measurements in kgf was used 
for analysis. The assessor gave verbal instructions to the patient in 
order to stimulate and improve strength at every measurement. 
•	 Patient satisfaction in the study group was assessed using a Likert 
scale that consisted of 5 answers (much worse, worse, same, better 
and much better). For statistical analysis, values ranging from 0 
(much worse) to 4 (much better) were used.
Intervention
For the participants in the 2 groups, a 3.2-mm thick night-time positioning 
splint was individually manufactured with thermoplast (ezeform®, Smith 
& Nephew) and fixed with Velcro® (Velcro Industries BV, Montevideo, 
Uruguay); the self-adhesive hook (rougher strap) and loop (soft strap) parts 
had 2 different widths (2.5 and 5.0 cm). The night-time positioning splint 
was manufactured for the more affected hand by an occupational therapist 
specialized in rheumatology. The splints were designed to place the hand 
in a functional position, providing approximately 10° of wrist dorsiflexion, 
25–30° of metacarpophalangeal joint flexion, 30° of proximal interphalan-
geal joint flexion and thumb abduction. The Velcro straps were positioned 
as follows: a wide strap at the height of the mid-forearm, another of the 
same width on the patient’s wrist and 2 narrower straps at the level of 
the metacarpophalangeal and proximal interphalangeal joints, with the 
self-adhesives placed on the palmar side of the splint for fixation.
Patients in the SG took the splint home after the first assessment 
and were instructed to use the appliance while sleeping. The patients 
received a table for recording the hours of daily use between assess-
ments. The patients were also instructed regarding the correct position, 
placement, removal and cleaning of the splint. For the CG, splints were 
stored in a cabinet between assessments; patients in this group only 
took the splint home after the last assessment.
Statistical analysis 
An intent-to-treat analysis was performed using the last-observa-
tion-carried-forward method. A level of significance of p < 0.05 was 
accepted for the trial. Pearson’s, χ2, Fisher’s Mann-Whitney U-test 
exact tests were used to determine homogeneity between groups. 
For normally distributed data, the dependent variables were analysed 
using a repeated-measures analysis of variance (ANoVA). The inde-
pendent variables in all analyses were group (SG vs CG; inter-subject 
factors) and time (baseline, 45 days, and 90 days; intra-subject fac-
tors). When interaction time × group was significant, an ANoVA for 
repeated measures was used to detect intra-group changes and either 
the Mann-Whitney U or independent sample t-tests were used in the 
inter-group comparison of the changes in scores at midline and treat-
ment completion. All tests were performed using SPSS version 10.0.1 
(SPSS, Chicago, IL, USA).
ReSULTS
A total of 127 patients were screened, of whom 50 were in-
cluded in the study after initial assessment. One participant in 
the SG and 2 in the CG dropped out during the intervention, 
leaving 49 participants at midline and 47 participants at the 
final assessment (Fig. 1). Patients who left treatment refused 
to undergo other evaluations; for these patients, any missing 
data were replaced with the last known value, even if this was 
the baseline value. Both groups were homogenous at baseline 
for all variables. Table I displays the population characteristics 
regarding age, duration of disease, gender, race, education 
level, profession, hand dominance, more affected hand, pain, 
HAQ, dASH, grip strength and pinch strength at baseline.
A decrease in pain in the more affected hand was observed 
in the SG, while pain in the CG remained constant, and a 
significant difference between groups over time was detected 
(p < 0.001). The comparison between groups at each time of 
evaluation revealed this difference at T90 (p = 0.001) (Fig. 
2A, Table II). HAQ scores also decreased in the SG while 
remaining constant in the CG, showing a significant difference 
between groups over time (p < 0.005). The comparison between 
Fig. 1. diagram showing the flow of participants through each stage of 
the trial. T0: baseline; T45: 45 days; T90: 90 days.
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groups at each time of evaluation revealed this difference at 
T90 (p < 0.001) (Fig. 2B, Table II). 
only 2 dASH modules (dASH Q2 and dASH Q3, refer-
ring to work and general upper limb symptoms, respectively) 
were analysed in the present study. Questions regarding sports 
activities and playing musical instruments were excluded, as 
only one of the 50 patients practiced regular physical activ-
ity (swimming) and played the guitar. Regarding dASH Q2, 
the groups behaved differently over time, with a decrease in 
scores in the SG and constant scores in the CG and a significant 
difference was detected (p = 0.011). The comparison between 
groups at each time of evaluation revealed this difference at 
T45 and T90 (p = 0.015 and p < 0.001) (Fig. 2C, Table II). For 
dASH Q3, the groups behaved differently over time, the 2 
groups remained unchanged until T45, after which the SG 
scores improved, while the CG scores remained constant and 
a significant difference between groups over time was detected 
(p < 0.010). The comparison between groups at each time of 
evaluation revealed this difference at T90 (p < 0.001) (Fig. 
2D, Table II).
A significant difference between groups was observed for 
grip strength over the 3 months (p = 0.04). The SG increased 
in strength, while the CG decreased in strength. However, 
no statistically significant differences were found between 
groups at T0 (p = 0.481), T45 (p = 0.982) or T90 (p = 0.144). 
The intra-group comparison revealed the SG performed differ-
ently over time (p = 0.019), with differences between T0/T45 
(p = 0.023) and T0/T90 (p = 0.009). The CG demonstrated no 
statistical differences over the 3 months of study (p = 0.365) 
(Fig. 3A, Table II).
There were significant differences in key pinch, palmar 
pinch and tip pinch strength over time (p = 0.034, p = 0.002 
and p = 0.004, respectively) (Table II). There was no statistical 
difference between groups regarding key pinch at each evalua-
tion; in the intra-group analysis, however, the SG demonstrated 
improved strength, which was statistically significant between 
T0/T45 (p = 0.020) and T0/T90 (p = 0.031), whereas the CG 
demonstrated no difference over time (p = 0.738) (Fig. 3B). 
In the palmar pinch analysis, there was a difference between 
groups at T90 (p = 0.023); in the intra-group analysis, the SG 
demonstrated improved strength, which was statistically sig-
nificant between T0/T45 (p = 0.009) and T0/T90 (p = 0.009), 
whereas the CG demonstrated no difference over time 




(n = 25) p
Age, years (mean (SD)) 51.16 (11.4) 50.72 (10.51) 0.992
Duration of disease, years  
(mean (SD))
10.12 (7.39) 9.02 (6.8) 0.587
Gender, female/male, n 20/5 21/4 0.713
Race, white/non-white, n 8/17 11/14 0.382
educational level, n
Incomplete high school 4 1 0.057
Incomplete primary school 7 17
Complete primary school 4 2
Incomplete secondary school 4 0
Complete secondary school 5 4
Illiterate 1 1
Profession, n




Hand dominance, right/left, n 21/4 23/2 0.384
More aching hand, right/left, n 15/10 13/12 0.569
Hand pain, VAS in cm  
(mean (SD))
6.33 (1.01) 5.86 (1.40) 0.196
HAQ score (mean (Sd)) 1.48 (0.68) 1.42 (0.50) 0.747
dASH Q2 (mean (Sd)) 39.77 (27.24) 52.81 (18.52) 0.111
dASH Q3 (mean (Sd)) 39.41 (20.67) 44.40 (15.61) 0.340
Key pinch strength, kgf (mean 
(SD))
3.10 (1.35) 3.87 (1.48) 0.481
Grip strength, kgf (mean (SD)) 8.9 (4.17) 10 (6.56) 0.061
Palmar pinch strength, kgf 
(mean (SD))
2.30 (1.26) 2.49 (1.04) 0.573
Tip pinch strength, kgf  
(mean (SD))
1.88 (1.14) 2.11 (0.95) 0.450
Sd: standard deviation; VAS: visual analogue scale; HAQ: Health 
Assessment Questionnaire; dASH: disabilities of the Arm, Shoulder 
and Hand questionnaire; Q2: music and work score; Q3: disability/
symptom score; kgf: kilogram force.
Fig. 2. Between-groups 
analysis over time for: 
(A) pain (VAS: visual 
analogue scale); (B) 
Heal th  Assessment 
Questionnaire (HAQ); 
(C) Disabilities of the 
Arm, shoulder and Hand 
(dASH), work and music 
scores (Q2); and (d) 
disability/symptom score 
(Q3). SG: study group; 
CG: control group.
J Rehabil Med 40
752 A. C. Silva et al.
(p = 0.558) (Fig. 3C). In the tip pinch analysis, there were no 
statistical differences at each evaluation (p = 0.450, p = 0.669 
and p = 0.072, respectively); in the intra-group analysis, 
however, the SG demonstrated improved strength, which was 
statistically significant between T0/T45 (p = 0.035), T0/T90 
(p = 0.002) and T45/T90 (p = 0.004), whereas the CG demon-
strated no differences over time (p = 0.850) (Fig. 3D).
The analysis of satisfaction with treatment in the SG revealed 
a statistically significant difference over time (p = 0.0179), 
with differences between T0/T90 (p = 0.0124) and T45/T90 
(p < 0.001). No significant difference was observed between 
T0/T45 (p = 0.677) (Table II). Mean time of splint use per night 
was 8 h (standard deviation 1.57; range 4.5–11 h) and showed 
no correlation with the other variables analysed.
DISCUSSION
Maini & Zvaifler (22) reported a peak incidence of RA be-
tween 40 and 60 years of age, similar to the mean age of the 
patients in the present study, which were 51.16 years in the SG 
Table II. Between-groups analysis of hand pain (VAS), HAQ score, DASH score, grip strength and pinch strength
T0 T45 T90
SG CG SG CG SG CG p1
Hand pain, VAS in cm (mean (Sd)) 6.33 (1.01) 5.86 (1.40) 4.7 (2.34) 5.24 (5.16) 3.4 (2.08) 5.79 (2.14) <0.001* 
p2 0.196 0.425 < 0.001*
HAQ score (mean (Sd)) 1.48 (0.68) 1.42 (0.50) 1.20 (0.63) 1.37 (0.38) 0.99 (0.54) 1.54 (0.43) <0.005* 
p2 0.747 0.250 <0.001*
dASH Q2 score (mean (Sd)) 39.77 (27.24) 52.81 (18.52) 32.38 (20.65) 49.31 (22.05) 19.03 (15.84) 53.75 (18.73) 0.011*
p2 0.111 0.015* < 0.001
dASH Q3 score (mean (Sd)) 39.41 (20.67) 44.40 (15.61) 36.79 (19.42) 42.90 (13.72) 25.42 (17.73) 46.49 (14.91) 0.010*
p2 0.340 0.206 <0.001*
Grip strength, kgf (mean (SD)) 8.9 (4.17) 10 (6.56) 10.74 (4.57) 10.77 (4.99) 12.04 (6.36) 9.55 (5.41) 0.04*
p2 0.481 0.982 0.144
Key pinch strength, kgf (mean (SD)) 3.10 (1.35) 3.87 (1.48) 3.68 (1.38) 3.69 (1.27) 3.95 (1.79) 3.71 (1.54) 0.034*
p2 0.061 0.972 0.613
Palmar pinch strength, kgf (mean (Sd)) 2.30 (1.26) 2.49 (1.04) 2.82 (1.26) 2.35 (0.88) 3.17 (1.55) 2.29 (1.04) 0.002*
p2 0.573 0.133 0.023*
Tip pinch strength, kgf (mean (SD)) 1.88 (1.14) 2.11 (0.95) 2.15 (1.11) 2.02 (0.93) 2.77 (1.50) 2.11 (0.97) 0.004*
p2 0.450 0.669 0.072
Patient satisfaction, n (%)
Much worse 1 (4) 0 (0) 0.0179*
Worse 2 (8) 1 (4)
Same 4 (16) 2 (8)
Better 13 (52) 11 (44)
Much better 5 (20) 11 (44)
*Significant p-value. 
Sd: standard deviation; SG: study group; CG: control group; T0: baseline; T45: after 45 days from baseline; T90: after 90 days from baseline; VAS: 
visual analogue scale; HAQ: Health Assessment Questionnaire; dASH: disabilities of the Arm, Shoulder and Hand questionnaire; Q2: music and 
work score; Q3: disability/symptom score; kgf: kilogram force; p1: p-value between groups over time; p2: p-value between groups at each time.
Fig. 3. Between-groups 
analysis over time for: 
(A) grip strength; (B) 
key pinch strength; (C) 
palmar pinch strength; 
and (D) tip pinch strength. 
kgf: kilogram force.
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and 50.72 years in the CG. The gender (female/male) ratio of 
patients with RA was 4.5:1, a ratio slightly higher than those 
reported by Maini & Zvaifler (22) and Albani & Carson (23) 
(3:1 and 2:3, respectively). This ratio may be explained by 
the greater time availability of women for participation in the 
study, as most female patients were housewives or worked as 
daily cleaning women, thereby facilitating their presence at the 
evaluations. Moreover, data in the literature demonstrate that 
the frequency of seeking medical and rehabilitation services 
is higher among women.
Pain is the main factor responsible for disability and im-
paired manual ability in patients with RA. Together with 
physical deformities, pain leads to dependence regarding the 
activities of daily living. The participants reported difficul-
ties in performing manual activities and attributed this fact to 
the pain in their hands, more specifically, in the wrist as well 
as distal and proximal interphalangeal joints. We believe the 
decrease in pain observed in the SG was due to a reduction 
in the inflammatory process, which allowed the patient to use 
his or her strength properly, consequently permitting a more 
satisfactory execution of daily activities. Similar findings were 
reported in a study by Nicholas et al. (10), in which patients 
had their hands immobilized by a splint and reduction in pain 
and inflammation was related to the time of splint use. 
The functional capacity of the participants, as evaluated 
by the HAQ, also improved in the SG. o’Connor et al. (24) 
demonstrated the importance of the HAQ associated with 
pain scores and related these values to the functional capac-
ity of individuals. Although the HAQ is the gold standard for 
the assessment of function in RA patients, the instrument is 
insufficient for the specific assessment of upper limb func-
tion. Therefore, the dASH was also used in the present study. 
According to dubert et al. (25), the dASH is an objective 
instrument that provides specific scores for the comparison of 
different types of treatment. Regarding the dASH Q2, which 
evaluates work-related characteristics, significant improvement 
was observed in the SG at T45 and lasted until the end of the 
study, whereas no improvement was observed in the CG. Sig-
nificant improvement was also observed regarding the dASH 
Q3 in the SG at T45 and T90, whereas CG tended to present 
poorer scores throughout the study, although this worsening 
did not reach statistical significance.
In the present study, the reduction in pain observed over 
the 3 months of intervention and monitored by the HAQ and 
dASH probably led to the improvement in upper limb function 
and symptoms, thus improving the performance of the partici-
pants in different daily activities. Since the positioning splint 
maintains the hand in a neutral resting position only at night, 
it does not impair the execution of daytime activities.
The improvement in the HAQ score was unexpected because 
this is a health-related questionnaire. We attempted to minimize 
bias by controlling other interventions, changes in medications 
and randomizing the patients immediately after the baseline 
assessment. We believe that the splint may account for the im-
proved HAQ score, as hand function has a significant impact on 
a patient’s life. Therefore, improvements in hand pain enabled 
the patients to perform activities of daily life better.
A significant difference between groups was also observed 
in terms of hand grip strength, as measured by Jamar dynamo-
meter. Key pinch, palmar pinch and tip pinch, measured with 
a pinch gauge, also differed significantly between groups. A 
number of uncontrolled studies on static wrist splints have 
shown a gain in grip strength (26–28) as observed in the present 
study. In contrast, dynamic hinged splints have been reported 
to reduce grip strength (29). 
The patients in the 2 groups did not undergo any other type 
of upper limb therapy during the 3 months of intervention other 
than the use of the splints, suggesting that the maintenance 
of grip and pinch strength in the study group was due to a 
reduction in pain and the inflammatory process. This finding 
indicates that night-time positioning splints do not impair grip 
or pinch strength, but rather improve them by decreasing pain 
and the inflammatory process.
Patient satisfaction with the use of the splint in the SG was 
evaluated using a Likert scale at T45 and T90. Most patients 
reported feeling either better or much better with the use of 
the appliance. It is important to note that the night-time posi-
tioning splint was moulded to the individual patient’s hand, 
respecting its shape and range of motion, and that the mate-
rial can be readjusted after fabrication if any pressure points 
cause discomfort.
One limitation of our study was the use of a control group 
with no intervention. However, our initial idea was to study 
whether the splint is better than no intervention. Further studies 
are necessary to compare the night-time splint with different 
forms of intervention. To minimize bias, the patients were 
randomized immediately following the baseline assessment; 
control subjects maintained their medication and did not un-
dergo any physical intervention. Moreover, our study followed 
the patients for only 3 months. It is also very important to study 
the long-term benefits of the splint. 
Nearly all patients in SG used the splint throughout the study. 
However, one patient admitted at the end of the 3 months that he 
had not used the splint correctly during the study period because 
he thought it would affect hand strength. A similar reluctance 
was reported by Pagnotta et al. (30), who found that the par-
ticipants feared a reduction in strength, but used the appliance 
because pain relief was believed to be more important. This 
shows how important it is to offer clear information or education, 
which may improve patient adherence to the intervention.
In conclusion, this present study demonstrated that the use 
of a night-time hand positioning splint by patients with RA 
decreases hand pain and improves grip and pinch strength, up-
per limb function and functional status, as well as promoting 
patient satisfaction.
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